Skip to main contentBack to Top

The unifying theme of the Tumor Signaling & Angiogenesis program is to build translational clinical trials based on innovative and novel research projects that focus on signaling cascades leading to uncontrolled cell growth and resistance to apoptosis.

The program goals are to identify dysregulated molecular signaling pathways that can be used as cancer-specific targets. Collectively the members of this program work cooperatively to study a variety of kinase targets involved in cancer cell proliferation and progression.

Targets identified in this program can be exploited to develop innovative approaches to cancer prevention and therapy that can be translated into clinical trials. The research into cancer cell signaling incorporates animal models in breast and colon cancer, as well as the pediatric cancer neuroblastoma, to study how specific signaling pathways are involved in the progression of cancer.

Program Members

photo of Ali Arbab, MD, PhD

Ali Arbab, MD, PhD

  • Professor
photo of Han-Fei Ding, PhD

Han-Fei Ding, PhD

  • Professor
photo of Ellen K. LeMosy, MD, PhD

Ellen K. LeMosy, MD, PhD

  • Associate Professor
photo of Honglin Li, PhD

Honglin Li, PhD

  • Associate Professor
photo of Betty Pace, MD

Betty Pace, MD

  • Professor
photo of Daitoku Sakamuro, PhD

Daitoku Sakamuro, PhD

  • Associate Professor
photo of Patricia V. Schoenlein, PhD

Patricia V. Schoenlein, PhD

  • Associate Professor
photo of Muthusamy Thangaraju, PhD

Muthusamy Thangaraju, PhD

  • Associate Professor
photo of Guangyu Wu, PhD

Guangyu Wu, PhD

  • Professor

Cancer Research News

Dr. Ravindra Kolhe stands in the forefront of a lab with his research associate looking on

High expression of cell death genes associated with early death from lung cancer

Patients with a high number of genes most associated with pathways that lead to cell death in lung cancer are at increased risk of dying early from their disease, researchers report.

Three black women

Georgia Cancer Center researcher launches health disparity study on breast cancer in Georgia’s Black community

Learn how a researcher at the Georgia Cancer Center is working to eliminate Georgia's breast cancer disparities.

Medical worker

Georgia Cancer Center receives grant to study clinical trial hesitancy in the Black community

Georgia Cancer Center researcher tackles clinical trial hesitancy in the Black community in the southeast.


$1.8 million NCI grant enables exploration of cancer-fighting compound isolated from Moroccan fungus

MCG and Georgia Cancer Center scientists have early evidence that the peptide EnnA, isolated from a fungus living symbiotically with a flowering plant known for its penchant of trapping flies, could be a powerful opponent of aggressive triple negative breast cancer.